S Cabriales

598 total citations
8 papers, 453 citations indexed

About

S Cabriales is a scholar working on Oncology, Genetics and Hematology. According to data from OpenAlex, S Cabriales has authored 8 papers receiving a total of 453 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 3 papers in Genetics and 3 papers in Hematology. Recurrent topics in S Cabriales's work include Viral-associated cancers and disorders (5 papers), Chronic Lymphocytic Leukemia Research (3 papers) and Multiple Myeloma Research and Treatments (3 papers). S Cabriales is often cited by papers focused on Viral-associated cancers and disorders (5 papers), Chronic Lymphocytic Leukemia Research (3 papers) and Multiple Myeloma Research and Treatments (3 papers). S Cabriales collaborates with scholars based in United States. S Cabriales's co-authors include Byron M. Espina, Anil Tulpule, Parkash S. Gill, David T. Scadden, Eric A. Forssen, Michael E. Ross, Franco M. Muggia, Howard A. Liebman, Joan A. Esplin and A Levine and has published in prestigious journals such as Journal of Clinical Oncology, Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology and PubMed.

In The Last Decade

S Cabriales

8 papers receiving 434 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S Cabriales United States 7 296 144 99 90 78 8 453
Catherine Sarta United States 10 218 0.7× 78 0.5× 110 1.1× 19 0.2× 24 0.3× 15 395
Joan A. Esplin United States 10 181 0.6× 67 0.5× 288 2.9× 79 0.9× 324 4.2× 13 775
Jennifer A. Crozier United States 10 267 0.9× 65 0.5× 137 1.4× 58 0.6× 20 0.3× 34 474
Carolyn Wasserheit United States 10 214 0.7× 54 0.4× 47 0.5× 13 0.1× 24 0.3× 15 319
Caroline Duhem Luxembourg 10 176 0.6× 36 0.3× 165 1.7× 24 0.3× 12 0.2× 17 566
Kirit Gala United States 8 119 0.4× 54 0.4× 69 0.7× 64 0.7× 13 0.2× 10 343
Ashish Bakshi India 11 127 0.4× 105 0.7× 69 0.7× 80 0.9× 6 0.1× 34 426
Lukas Kraehenbuehl United States 9 452 1.5× 50 0.3× 190 1.9× 22 0.2× 23 0.3× 23 762
Runzhe Chen China 14 241 0.8× 44 0.3× 144 1.5× 31 0.3× 11 0.1× 40 502
Martin Schwonzen Germany 13 238 0.8× 113 0.8× 106 1.1× 16 0.2× 7 0.1× 27 510

Countries citing papers authored by S Cabriales

Since Specialization
Citations

This map shows the geographic impact of S Cabriales's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S Cabriales with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S Cabriales more than expected).

Fields of papers citing papers by S Cabriales

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S Cabriales. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S Cabriales. The network helps show where S Cabriales may publish in the future.

Co-authorship network of co-authors of S Cabriales

This figure shows the co-authorship network connecting the top 25 collaborators of S Cabriales. A scholar is included among the top collaborators of S Cabriales based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S Cabriales. S Cabriales is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Tulpule, Anil, David T. Scadden, Byron M. Espina, et al.. (2000). Results of a Randomized Study of IM862 Nasal Solution in the Treatment of AIDS-Related Kaposi’s Sarcoma. Journal of Clinical Oncology. 18(4). 716–716. 61 indexed citations
2.
Gill, Parkash S., Anil Tulpule, Byron M. Espina, et al.. (1999). Paclitaxel Is Safe and Effective in the Treatment of Advanced AIDS-Related Kaposi's Sarcoma. Journal of Clinical Oncology. 17(6). 1876–1876. 135 indexed citations
3.
Tulpule, Anil, Rex Yung, J Wernz, et al.. (1998). Phase II trial of liposomal daunorubicin in the treatment of AIDS-related pulmonary Kaposi's sarcoma.. Journal of Clinical Oncology. 16(10). 3369–3374. 39 indexed citations
4.
Gill, Parkash S., David T. Scadden, Anil Tulpule, et al.. (1998). PRELIMINARY RESULTS OF IM-862 NASAL SOLUTION IN THE TREATMENT OF PATIENTS WITH AIDS-RELATED KAPOSI'S SARCOMA.. Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology. 17(4). A25–A25. 3 indexed citations
5.
Cabriales, S, et al.. (1998). Extravasation of liposomal daunorubicin in patients with AIDS-associated Kaposi's sarcoma: a report of four cases.. PubMed. 25(1). 67–70. 16 indexed citations
6.
Gill, Parkash S., David T. Scadden, JE Groopman, et al.. (1997). LOW DOSE PACLITAXEL (TAXOL⊙) IS HIGHLY EFFECTIVE IN THE TREATMENT OF PATIENTS WITH ADVANCED AIDS-RELATED KAPOSI'S SARCOMA. Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology. 14(4). A35–A35. 6 indexed citations
7.
Ps, Gill, et al.. (1997). AIDS Clinical Trials Group Study 094: a phase I/II trial of ABV chemotherapy with zidovudine and recombinant human GM-CSF in AIDS-related Kaposi's sarcoma.. PubMed. 3(5). 278–83. 11 indexed citations
8.
Gill, Parkash S., Byron M. Espina, Franco M. Muggia, et al.. (1995). Phase I/II clinical and pharmacokinetic evaluation of liposomal daunorubicin.. Journal of Clinical Oncology. 13(4). 996–1003. 182 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026